Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LQDA | US
-0.16
-0.44%
Healthcare
Biotechnology
30/06/2024
09/03/2026
35.87
35.32
36.56
34.92
Liquidia Corporation a biopharmaceutical company develops manufactures and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. The company distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville North Carolina.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
High Short-term Volatility
Midcap (2B - 10B USD)
High Short percentage (> 15%)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
74.8%1 month
73.6%3 months
65.5%6 months
62.4%-
-
15.42
0.05
0.02
-9.43
56.39
-
-95.84M
3.03B
3.03B
-
-743.29
-
-23.50
-181.73
11.41
21.63
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
8.71
Range1M
14.57
Range3M
17.55
Rel. volume
0.79
Price X volume
57.52M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc. American Depositary Shares | GPCR | Biotechnology | 56.5 | 3.23B | -2.13% | n/a | 0.51% |
| Denali Therapeutics Inc | DNLI | Biotechnology | 21.31 | 3.05B | 8.23% | n/a | 3.51% |
| IDEAYA Biosciences Inc | IDYA | Biotechnology | 35.08 | 2.96B | 5.69% | n/a | 0.20% |
| ARCUTIS BIOTHERAPEUTICS INC. | ARQT | Biotechnology | 24.82 | 2.90B | 3.42% | n/a | 111.34% |
| Tarsus Pharmaceuticals Inc | TARS | Biotechnology | 74.49 | 2.83B | 1.68% | n/a | 28.62% |
| NewAmsterdam Pharma Company N.V. Ordinary Shares | NAMS | Biotechnology | 30.77 | 2.77B | 3.05% | n/a | 0.15% |
| Edgewise Therapeutics Inc. | EWTX | Biotechnology | 28.66 | 2.69B | 3.02% | n/a | 0.98% |
| Spruce Biosciences Inc | SPRB | Biotechnology | 62.11 | 2.57B | 11.17% | n/a | 6.24% |
| Veracyte Inc | VCYT | Biotechnology | 33.37 | 2.56B | -1.42% | n/a | 1.83% |
| DBV Technologies S.A | DBVT | Biotechnology | 22.9 | 2.44B | 4.71% | n/a | 16.59% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| LCI Industries | LCII | Recreational Vehicles | 128.77 | 3.28B | -0.71% | 25.82 | 77.66% |
| VeriFone Systems Inc | PAY | Building Products & Equipment | 25.78 | 3.21B | -0.23% | 102.46 | 2.10% |
| Polaris Industries Inc | PII | Recreational Vehicles | 52.73 | 2.94B | -2.96% | 14.48 | 170.51% |
| Harley-Davidson Inc | HOG | Recreational Vehicles | 18.77 | 2.47B | -2.29% | 7.33 | 218.58% |
| HNI Corporation | HNI | Building Products & Equipment | 41.37 | 1.95B | -0.17% | 22.12 | 76.47% |
| Pitney Bowes Inc | PBI | Building Products & Equipment | 10.67 | 1.92B | 0.85% | n/a | -571.93% |
| ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 14.07 | 1.41B | 1.22% | n/a | 19.46% |
| Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 36.22 | 1.14B | 1.06% | 51.60 | 88.92% |
| Winnebago Industries Inc | WGO | Recreational Vehicles | 35.25 | 1.02B | -2.87% | 22.53 | 56.33% |
| Janus International Group Inc. | JBI | Building Products & Equipment | 5.39 | 783.29M | 1.89% | 11.62 | 116.21% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -9.43 | 0.53 | Cheaper |
| Ent. to Revenue | 56.39 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 15.42 | 15.55 | Par |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 65.53 | 72.80 | Par |
| Debt to Equity | 0.05 | -1.23 | Expensive |
| Debt to Assets | 0.02 | 0.25 | Cheaper |
| Market Cap | 3.03B | 3.66B | Par |